Abnormally increased carotid intima media-thickness and elasticity in patients with Morquio A disease

Raymond Y Wang1,2, Kyle D Rudser3, Donald R Dengel4

  • 1Division of Metabolic Disorders, CHOC Children's Specialists, Orange, CA, USA. rawang@choc.org.

Abstract

Insights

Cardiovascular disease is common in mucopolysaccharidoses (MPS). This study found Morquio A disease (MPS IVA) patients have increased carotid intima-media thickness and unexpected carotid hyperelasticity, suggesting unique vascular involvement.

Area of Science:

  • Vascular biology
  • Rare genetic disorders
  • Cardiology

Background:

  • Cardiovascular disease is a major cause of mortality in mucopolysaccharidoses (MPS).
  • Cardiovascular anatomy and dysfunction in MPS IVA (Morquio A disease) are not well characterized.
  • Understanding vascular changes in MPS IVA is crucial for patient management.

Purpose of the Study:

  • To compare carotid artery structure and elasticity in MPS IVA patients versus other MPS patients and healthy controls.
  • To quantify cardiac structural and functional abnormalities in MPS IVA.
  • To elucidate the specific vascular pathology in Morquio A disease.

Main Methods:

  • Prospective, multi-center study involving echocardiogram and carotid ultrasound.
  • Evaluated 12 patients with Morquio A disease, compared with other MPS patients and healthy controls.
  • Statistical analysis adjusted for age, sex, and height using robust variance estimation.

Main Results:

  • MPS IVA patients showed significantly increased carotid intima-media thickness (cIMT) compared to controls.
  • MPS IVA patients exhibited significantly greater carotid elasticity than controls and other MPS patients.
  • Aortic root dilatation and mitral/aortic valve thickening were prevalent, though significant valve dysfunction was less common.

Conclusions:

  • MPS IVA patients display increased cIMT and paradoxical carotid hyperelasticity, contrasting with other MPS types.
  • Aortic root dilatation suggests arterial elastin dysfunction, while carotid hyperelasticity points to the role of proteoglycans in vascular health.
  • Further research using MPS I and IVA models may clarify the role of glycosaminoglycan-bearing proteoglycans in arterial function.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
680
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
289
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
297
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
370